These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1154 related items for PubMed ID: 17636112

  • 21. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
    Goh KT, Tan KL, Kong KH, Oon CJ, Chan SH.
    Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
    [Abstract] [Full Text] [Related]

  • 22. Presence of immune memory and immunity to hepatitis B virus in adults after neonatal hepatitis B vaccination.
    Zhu CL, Liu P, Chen T, Ni Z, Lu LL, Huang F, Lu J, Sun Z, Qu C.
    Vaccine; 2011 Oct 13; 29(44):7835-41. PubMed ID: 21816197
    [Abstract] [Full Text] [Related]

  • 23. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen.
    Huang LM, Chiang BL, Lee CY, Lee PI, Chi WK, Chang MH.
    Hepatology; 1999 Mar 13; 29(3):954-9. PubMed ID: 10051503
    [Abstract] [Full Text] [Related]

  • 24. Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high.
    Wu Q, Zhuang GH, Wang XL, Wang LR, Li N, Zhang M.
    Vaccine; 2011 Mar 09; 29(12):2302-7. PubMed ID: 21277403
    [Abstract] [Full Text] [Related]

  • 25. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
    Su FH, Bai CH, Chu FY, Lin YS, Su CT, Yeh CC.
    Vaccine; 2012 Jun 08; 30(27):4034-9. PubMed ID: 22531558
    [Abstract] [Full Text] [Related]

  • 26. Effectiveness of a bivalent Haemophilus influenzae type B-hepatitis B vaccine in preventing hepatitis B virus infection among children born to hepatitis B e antigen-positive carrier mothers.
    Doherty R, Garland S, Wright M, Bulotsky M, Liss C, Lakkis H, Nikas A, Straus W.
    Pediatr Infect Dis J; 2009 Sep 08; 28(9):777-81. PubMed ID: 19636283
    [Abstract] [Full Text] [Related]

  • 27. Hepatitis B vaccination in children: five year booster study.
    Milne A, Krugman S, Waldon JA, Hadler SC, Lucas CR, Moyes CD, Pearce NE.
    N Z Med J; 1992 Aug 26; 105(940):336-8. PubMed ID: 1508451
    [Abstract] [Full Text] [Related]

  • 28. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ, Gao YH, Lu W, Jin CD, Zeng Y, Yan L, Ding F, Li T, Liu XE, Zhuang H.
    Hum Vaccin Immunother; 2017 Apr 03; 13(4):909-915. PubMed ID: 27874311
    [Abstract] [Full Text] [Related]

  • 29. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents.
    Gabbuti A, Romanò L, Blanc P, Meacci F, Amendola A, Mele A, Mazzotta F, Zanetti AR.
    Vaccine; 2007 Apr 20; 25(16):3129-32. PubMed ID: 17291637
    [Abstract] [Full Text] [Related]

  • 30. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR, Mariano A, Romanò L, D'Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, Parlato A, Zamparo E, Zotti C, Stroffolini T, Mele A, Study Group.
    Lancet; 2007 Apr 20; 366(9494):1379-84. PubMed ID: 16226616
    [Abstract] [Full Text] [Related]

  • 31. The persistence of anti-hepatitis B surface antibodies to three years of age: is a hepatitis B vaccine booster required?
    Gunn TR, Woodfield DG.
    N Z Med J; 1993 Nov 24; 106(968):499-501. PubMed ID: 8247433
    [Abstract] [Full Text] [Related]

  • 32. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization.
    Lu CY, Ni YH, Chiang BL, Chen PJ, Chang MH, Chang LY, Su IJ, Kuo HS, Huang LM, Chen DS, Lee CY.
    J Infect Dis; 2008 May 15; 197(10):1419-26. PubMed ID: 18444799
    [Abstract] [Full Text] [Related]

  • 33. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II, Sami SM, Salama SI, Foud WA, Abdel Hamid AT, Said ZN.
    Egypt J Immunol; 2014 May 15; 21(1):13-26. PubMed ID: 25204041
    [Abstract] [Full Text] [Related]

  • 34. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India.
    Velu V, Nandakumar S, Shanmugam S, Shankar EM, Thangavel S, Kulkarni PS, Thyagarajan SP.
    Pediatr Infect Dis J; 2007 Nov 15; 26(11):1038-41. PubMed ID: 17984812
    [Abstract] [Full Text] [Related]

  • 35. Hepatitis B revaccination in healthy non-responder Chinese children: five-year follow-up of immune response and immunologic memory.
    Zhuang GH, Yan H, Wang XL, Hwang LY, Wu Q, Wang LR, Gao HY.
    Vaccine; 2006 Mar 15; 24(12):2186-92. PubMed ID: 16310902
    [Abstract] [Full Text] [Related]

  • 36. The effects of booster vaccination of hepatitis B vaccine on anti-HBV surface antigen negative children 11-15 years after primary vaccination.
    Yao J, Ren J, Shen L, Chen Y, Liang X, Cui F, Li Q, Jiang Z, Wang F.
    Hum Vaccin; 2011 Oct 15; 7(10):1055-9. PubMed ID: 21989290
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan.
    Kao JT, Wang JH, Hung CH, Yen YH, Hung SF, Hu TH, Lee CM, Lu SN.
    Vaccine; 2009 Mar 13; 27(12):1858-62. PubMed ID: 19186203
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 58.